Thiamavance 10 mg/ml oral solution for cats
Thiamavance 10 mg/ml oral solution for cats
Authorised
- Thiamazole
Product identification
Medicine name:
Thiamavance 10 mg/ml oral solution for cats
THIAMAVANCE 10 mg/ml SOLUCION ORAL PARA GATOS
Active substance:
- Thiamazole
Target species:
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Thiamazole10.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH03BB02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Package description:
- Cardboard box containing 1 bottle of 30 ml and 1 oral syringe of 1 ml graduated in 0.5 mg.
- Cardboard box containing 1 bottle of 30 ml and 1 oral syringe of 1 ml graduated in 1.25 mg
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application - change in active substance(s) (Article 19(1)(a) of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
Responsible authority:
- Spanish Agency Of Medicines And Medical Devices
Authorisation number:
- 4497 ESP
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0449/001
Concerned member states:
-
Austria
-
Belgium
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 10/02/2026
Spanish (PDF)
Published on: 10/02/2026
